by In2Pharma | Dec 18, 2025 | News
Belgium A Stock Monitoring Tool (SMT) will be implemented by the government. The goal of this tool is to anticipate and manage (un)availabilities of medicinal products for human use. A Royal Decree is being drafted and includes mandatory reporting: By MAHs, parallel...
by In2Pharma | Oct 10, 2024 | News
The Netherlands As of 25 October 2024, a new version of the notification form of the “Meldpunt geneesmiddelentekorten en -defecten” will become available. The new form will include the following changes: The addition of the option to adjust the period indication of a...
